Physicians and patients should carefully weigh the risks and benefits of aspirin as therapy to prevent cardiovascular problems, according to new recommendations from the US Preventive Services Task Force.
The new recommendations update those issued in 2002 based on more recent data demonstrating that the risks and benefits of preventive aspirin therapy differ between men and women (http://www.ahrq.gov/clinic/uspstf/uspsasmi.htm). Accordingly, the task force now recommends aspirin use for men aged 45 to 79 years when the potential benefit of preventing myocardial infarction outweighs the potential harm of increased risk of gastrointestinal hemorrhage and for women aged 55 to 79 years when the potential benefit of reducing ischemic stroke outweighs the risk of increased gastrointestinal bleeding.
Kuehn BM. New Aspirin Recommendations. JAMA. 2009;301(16):1647. doi:10.1001/jama.2009.539